Benjamin Graham · Deep value défensif
Is Regeneron Pharmaceuticals, Inc. (REGN) a Benjamin Graham Stock?
Meets 3/7 Graham criteria, partially qualifies.
66/100
Mitigé
3/7 critères validés
Les critères de Benjamin Graham, appliqués à REGN
P/E ≤ 15
clé16.4x
P/B ≤ 1.5
clé2.3x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
0.1x
Comment REGN se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$75.69B
PER (TTM)
16.4x
ROIC (TTM)
8.53%
Marge brute
84.55%
Autres analyses Benjamin Graham
Questions fréquentes
What is REGN's Benjamin Graham fit score?
REGN scores 66/100 on our Benjamin Graham fit engine. Meets 3/7 Graham criteria, partially qualifies.
Does Benjamin Graham actually own REGN?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends REGN.
How often is this score updated?
REGN's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Benjamin Graham possède ou recommande REGN personnellement.
